Effect of food on the bioavailability of labetalol. 1980

R Mäntylä, and H Allonen, and J Kanto, and T Kleimola, and R Sellman

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007741 Labetalol A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS. AH-5158,Albetol,Apo-Labetalol,Dilevalol,Labetalol Hydrochloride,Labetalol, (R,R)-Isomer,Labetolol,Normodyne,Presolol,R,R-Labetalol,SCH-19927,Trandate,AH 5158,AH5158,Apo Labetalol,ApoLabetalol,Hydrochloride, Labetalol,R,R Labetalol,SCH 19927,SCH19927
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004983 Ethanolamines AMINO ALCOHOLS containing the ETHANOLAMINE; (-NH2CH2CHOH) group and its derivatives. Aminoethanols
D005260 Female Females
D005502 Food Substances taken in by the body to provide nourishment. Foods
D005769 Gastrointestinal Motility The motor activity of the GASTROINTESTINAL TRACT. Intestinal Motility,Gastrointestinal Motilities,Intestinal Motilities,Motilities, Gastrointestinal,Motilities, Intestinal,Motility, Gastrointestinal,Motility, Intestinal
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes

Related Publications

R Mäntylä, and H Allonen, and J Kanto, and T Kleimola, and R Sellman
January 1980, Annual review of pharmacology and toxicology,
R Mäntylä, and H Allonen, and J Kanto, and T Kleimola, and R Sellman
January 1986, European journal of clinical pharmacology,
R Mäntylä, and H Allonen, and J Kanto, and T Kleimola, and R Sellman
November 1989, Zeitschrift fur Stomatologie (1984),
R Mäntylä, and H Allonen, and J Kanto, and T Kleimola, and R Sellman
April 2001, Biopharmaceutics & drug disposition,
R Mäntylä, and H Allonen, and J Kanto, and T Kleimola, and R Sellman
March 1981, Lancet (London, England),
R Mäntylä, and H Allonen, and J Kanto, and T Kleimola, and R Sellman
January 1976, Journal of clinical pharmacology,
R Mäntylä, and H Allonen, and J Kanto, and T Kleimola, and R Sellman
March 2017, Cancer chemotherapy and pharmacology,
R Mäntylä, and H Allonen, and J Kanto, and T Kleimola, and R Sellman
January 1978, Acta medica Scandinavica,
R Mäntylä, and H Allonen, and J Kanto, and T Kleimola, and R Sellman
October 1994, Journal of clinical pharmacology,
R Mäntylä, and H Allonen, and J Kanto, and T Kleimola, and R Sellman
January 1982, European journal of clinical pharmacology,
Copied contents to your clipboard!